Resveratrol protects RPE cells from sodium iodate by modulating PPARα and PPARδ

Experimental Eye Research

Volumn 118, Issue , 2014, Pages 100-108

  Qin, Suofu ^a   Lu, Yimin ^a   Rodrigues, Gerard A ^a  

^a ALLERGAN INC   (United States)

Author keywords

PPAR; Resveratrol; ROS; RPE; Sodium iodate; Survival

Indexed keywords

INTERLEUKIN 8; ISOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; REACTIVE OXYGEN METABOLITE; RESVERATROL; SODIUM IODATE;

ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE SILENCING; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 84890243022     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.11.010     Document Type: Article

References (39)

1. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
2. Baich A., Ziegler M. The effect of sodium iodate and melanin on the formation of glyoxylate. Pigment Cell Res. 1992, 5:394-395.
3. Behnam J.T., Williams E.L., Brink S., Rumsby G., Danpure C.J. Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells. Biochem. J. 2006, 394:409-416.
4. Billin A.N. PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home. Expert Opin. Investig. Drugs 2008, 17:1465-1471.
5. Cai J., Nelson K.C., Wu M., Sternberg P., Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 2000, 19:205-221.
6. Cano M., Thimmalappula R., Fujihara M., Nagai N., Sporn M., Wang A.L., Neufeld A.H., Biswal S., Handa J.T. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration. Vision Res. 2010, 50:652-664.
7. Chou W.W., Chen K.C., Wang Y.S., Wang J.Y., Liang C.L., Juo S.H. The role of SIRT1/AKT/ERK pathway in ultraviolet B induced damage on human retinal pigment epithelial cells. Toxicol. InVitro (An International Journal Published in Association with BIBRA) 2013, 27:1728-1736.
8. Deplanque D., Gele P., Petrault O., Six I., Furman C., Bouly M., Nion S., Dupuis B., Leys D., Fruchart J.C., Cecchelli R., Staels B., Duriez P., Bordet R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J.Neurosci. 2003, 23:6264-6271.
9. Di Paola R., Esposito E., Mazzon E., Paterniti I., Galuppo M., Cuzzocrea S. GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury. J.Leukoc. Biol. 2010, 88:291-301.
10. Dugas B., Charbonnier S., Baarine M., Ragot K., Delmas D., Menetrier F., Lherminier J., Malvitte L., Khalfaoui T., Bron A., Creuzot-Garcher C., Latruffe N., Lizard G. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur. J. Nutr. 2010, 49:435-446.
11. Enzmann V., Row B.W., Yamauchi Y., Kheirandish L., Gozal D., Kaplan H.J., McCall M.A. Behavioral and anatomical abnormalities in a sodium iodate-induced model of retinal pigment epithelium degeneration. Exp. Eye Res. 2006, 82:441-448.
12. Evans J.R. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:227-253.
13. Fan Y., Wang Y., Tang Z., Zhang H., Qin X., Zhu Y., Guan Y., Wang X., Staels B., Chien S., Wang N. Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:315-321.
14. Fuenzalida K., Quintanilla R., Ramos P., Piderit D., Fuentealba R.A., Martinez G., Inestrosa N.C., Bronfman M. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J.Biol. Chem. 2007, 282:37006-37015.
15. Gelosa P., Banfi C., Gianella A., Brioschi M., Pignieri A., Nobili E., Castiglioni L., Cimino M., Tremoli E., Sironi L. Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. J.Pharmacol. Exp. Ther. 2010, 335:324-331.
16. Goverdhan S.V., Ennis S., Hannan S.R., Madhusudhana K.C., Cree A.J., Luff A.J., Lotery A.J. Interleukin-8 promoter polymorphism-251A/T is a risk factor for age-related macular degeneration. Br. J. Ophthalmol. 2008, 92:537-540.
17. He X., Wang L., Szklarz G., Bi Y., Ma Q. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J.Pharmacol. Exp. Ther. 2012, 342:81-90.
18. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci. Lett. 2003, 352:203-206.
19. Jiang B., Liang P., Zhang B., Huang X., Xiao X. Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis. Free Radic. Biol. Med. 2009, 46:555-563.
20. Juhasz B., Varga B., Gesztelyi R., Kemeny-Beke A., Zsuga J., Tosaki A. Resveratrol: a multifunctional cytoprotective molecule. Curr. Pharm. Biotechnol. 2010, 11:810-818.
21. Kiuchi K., Yoshizawa K., Shikata N., Moriguchi K., Tsubura A. Morphologic characteristics of retinal degeneration induced by sodium iodate in mice. Curr. Eye Res. 2002, 25:373-379.
22. Kota B.P., Huang T.H., Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 2005, 51:85-94.
23. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., Curtiss L.K. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 2003, 302:453-457.
24. Leung K.W., Barnstable C.J., Tombran-Tink J. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol. Immunol. 2009, 46:1374-1386.
25. Mansoor S., Gupta N., Patil A.J., Estrago-Franco M.F., Ramirez C., Migon R., Sapkal A., Kuppermann B.D., Kenney M.C. Inhibition of apoptosis in human retinal pigment epithelial cells treated with benzo(e)pyrene, a toxic component of cigarette smoke. Invest. Ophthalmol. Vis. Sci. 2010, 51:2601-2607.
26. McBee J.K., Palczewski K., Baehr W., Pepperberg D.R. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog. Retin. Eye Res. 2001, 20:469-529.
27. Nguyen-Legros J., Hicks D. Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium. Int. Rev. Cytol. 2000, 196:245-313.
28. Pintea A., Rugina D., Pop R., Bunea A., Socaciu C., Diehl H.A. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J.Ocul. Pharmacol. Ther. 2011, 27:315-321.
29. Poldelski V., Johnson A., Wright S., Rosa V.D., Zager R.A. Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am. J. Kidney Dis. 2001, 38:339-348.
30. Qin S. Oxidative damage of retinal pigment epithelial cells and age-related macular degeneration. Drug Dev. Res. 2007, 68:213-225.
31. Qin S., De Vries G.W. alpha2 but not alpha1 AMP-activated protein kinase mediates oxidative stress-induced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments. J.Biol. Chem. 2008, 283:6744-6751.
32. Qin S., Rodrigues G.A. Role of reactive oxygen species in the oathogenesis of age-related macular degeneration. Handbook of Free Radicals: Formation, Types and Effects 2010, 167-196. Nova Science Publishers, Inc., New York. D. Kozyrev, V. Slutsky (Eds.).
33. Robb E.L., Stuart J.A. trans-Resveratrol as a neuroprotectant. Molecules 2010, 15:1196-1212.
34. Sheu S.J., Liu N.C., Chen J.L. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J.Ocul. Pharmacol. Ther. 2010, 26:231-236.
35. Shin S.M., Cho I.J., Kim S.G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol. 2009, 76:884-895.
36. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85:845-881.
37. Thompson D.A., Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog. Retin. Eye Res. 2003, 22:683-703.
38. Tsai Y.Y., Lin J.M., Wan L., Lin H.J., Tsai Y., Lee C.C., Tsai C.H., Tsai F.J., Tseng S.H. Interleukin gene polymorphisms in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:693-698.
39. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J.Immunol. 2005, 175:3339-3346.